Akebia Therapeutics has released its financial results, but there is confusion about the specific quarter being reported, with some outlets referencing Q4 2025 and others referencing Q1 2026. The company's earnings appear to have missed forecasts, leading to a decline in stock price. The exact details of the earnings report are unclear due to conflicting information.